Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice

被引:324
作者
Halper-Stromberg, Ariel [1 ]
Lu, Ching-Lan [1 ,2 ]
Klein, Florian [1 ]
Horwitz, Joshua A. [1 ]
Bournazos, Stylianos [3 ]
Nogueira, Lilian [1 ]
Eisenreich, Thomas R. [1 ]
Liu, Cassie [1 ]
Gazumyan, Anna [1 ]
Schaefer, Uwe [4 ]
Furze, Rebecca C. [5 ]
Seaman, Michael S. [6 ]
Prinjha, Rab [5 ]
Tarakhovsky, Alexander [4 ]
Ravetch, Jeffrey V. [3 ]
Nussenzweig, Michel C. [1 ]
机构
[1] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA
[2] Weill Cornell Med Coll, New York, NY 10065 USA
[3] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA
[4] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA
[5] GlaxoSmithKline, Med Res Ctr, Immuno Inflammat Therapy Area, Stevenage SG1 2NY, Herts, England
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
ACTIVE ANTIRETROVIRAL THERAPY; INFECTED RHESUS-MONKEYS; TO-CELL SPREAD; IMMUNE-RESPONSES; SYNERGISTIC ACTIVATION; MONOCLONAL-ANTIBODIES; IN-VIVO; MACAQUES; VIREMIA; CYTOTOXICITY;
D O I
10.1016/j.cell.2014.07.043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Latent reservoirs of HIV-1-infected cells are refractory to antiretroviral therapies (ART) and remain the major barrier to curing HIV-1. Because latently infected cells are long-lived, immunologically invisible, and may undergo homeostatic proliferation, a "shock and kill" approach has been proposed to eradicate this reservoir by combining ART with inducers of viral transcription. However, all attempts to alter the HIV-1 reservoir in vivo have failed to date. Using humanized mice, we show that broadly neutralizing antibodies (bNAbs) can interfere with establishment of a silent reservoir by Fc-FcR-mediated mechanisms. In established infection, bNAbs or bNAbs plus single inducers are ineffective in preventing viral rebound. However, bNAbs plus a combination of inducers that act by independent mechanisms synergize to decrease the reservoir as measured by viral rebound. Thus, combinations of inducers and bNAbs constitute a therapeutic strategy that impacts the establishment and maintenance of the HIV-1 reservoir in humanized mice.
引用
收藏
页码:989 / 999
页数:11
相关论文
共 66 条
[1]   Cell-Cell Transmission Enables HIV-1 to Evade Inhibition by Potent CD4bs Directed Antibodies [J].
Abela, Irene A. ;
Berlinger, Livia ;
Schanz, Merle ;
Reynell, Lucy ;
Guenthard, Huldrych F. ;
Rusert, Peter ;
Trkola, Alexandra .
PLOS PATHOGENS, 2012, 8 (04)
[2]   Highly Active Antiretroviral Therapies Are Effective against HIV-1 Cell-to-Cell Transmission [J].
Agosto, Luis M. ;
Zhong, Peng ;
Munro, James ;
Mothes, Walther .
PLOS PATHOGENS, 2014, 10 (02)
[3]   REMOVAL OF ENDOTOXIN FROM PROTEIN SOLUTIONS BY PHASE-SEPARATION USING TRITON X-114 [J].
AIDA, Y ;
PABST, MJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 132 (02) :191-195
[4]   Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy [J].
Archin, N. M. ;
Liberty, A. L. ;
Kashuba, A. D. ;
Choudhary, S. K. ;
Kuruc, J. D. ;
Crooks, A. M. ;
Parker, D. C. ;
Anderson, E. M. ;
Kearney, M. F. ;
Strain, M. C. ;
Richman, D. D. ;
Hudgens, M. G. ;
Bosch, R. J. ;
Coffin, J. M. ;
Eron, J. J. ;
Hazuda, D. J. ;
Margolis, D. M. .
NATURE, 2012, 487 (7408) :482-U1650
[5]   Expression of Latent HIV Induced by the Potent HDAC Inhibitor Suberoylanilide Hydroxamic Acid [J].
Archin, Nancie M. ;
Espeseth, Amy ;
Parker, Daniel ;
Cheema, Manzoor ;
Hazuda, Daria ;
Margolis, David M. .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2009, 25 (02) :207-212
[6]  
Archin NM, 2014, J INFECT DIS
[7]   Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys [J].
Barouch, Dan H. ;
Whitney, James B. ;
Moldt, Brian ;
Klein, Florian ;
Oliveira, Thiago Y. ;
Liu, Jinyan ;
Stephenson, Kathryn E. ;
Chang, Hui-Wen ;
Shekhar, Karthik ;
Gupta, Sanjana ;
Nkolola, Joseph P. ;
Seaman, Michael S. ;
Smith, Kaitlin M. ;
Borducchi, Erica N. ;
Cabral, Crystal ;
Smith, Jeffrey Y. ;
Blackmore, Stephen ;
Sanisetty, Srisowmya ;
Perry, James R. ;
Beck, Matthew ;
Lewis, Mark G. ;
Rinaldi, William ;
Chakraborty, Arup K. ;
Poignard, Pascal ;
Nussenzweig, Michel C. ;
Burton, Dennis R. .
NATURE, 2013, 503 (7475) :224-+
[8]   BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism [J].
Boehm, Daniela ;
Calvanese, Vincenzo ;
Dar, Roy D. ;
Xing, Sifei ;
Schroeder, Sebastian ;
Martins, Laura ;
Aull, Katherine ;
Li, Pao-Chen ;
Planelles, Vicente ;
Bradner, James E. ;
Zhou, Ming-Ming ;
Siliciano, Robert F. ;
Weinberger, Leor ;
Verdin, Eric ;
Ott, Melanie .
CELL CYCLE, 2013, 12 (03) :452-462
[9]   Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family [J].
Bonsignori, Mattia ;
Pollara, Justin ;
Moody, M. Anthony ;
Alpert, Michael D. ;
Chen, Xi ;
Hwang, Kwan-Ki ;
Gilbert, Peter B. ;
Huang, Ying ;
Gurley, Thaddeus C. ;
Kozink, Daniel M. ;
Marshall, Dawn J. ;
Whitesides, John F. ;
Tsao, Chun-Yen ;
Kaewkungwal, Jaranit ;
Nitayaphan, Sorachai ;
Pitisuttithum, Punnee ;
Rerks-Ngarm, Supachai ;
Kim, Jerome H. ;
Michael, Nelson L. ;
Tomaras, Georgia D. ;
Montefiori, David C. ;
Lewis, George K. ;
DeVico, Anthony ;
Evans, David T. ;
Ferrari, Guido ;
Liao, Hua-Xin ;
Haynes, Barton F. .
JOURNAL OF VIROLOGY, 2012, 86 (21) :11521-11532
[10]  
Brehm M.A., 2014, J IMMUNOL METHODS